Impact figures for 2022 have been released and The British Journal of Haematology (BJHaem) has been awarded a score of 8.6.
Impact factors measure the influence of a journal within its academic circles. This is based on how many times a journal has been cited or used in any other research of that year. The higher the impact score, the more influential the journal.
This score marks the highest ever for BJHaem, which was established in 1955 to help inform and educate its readership in all aspects of the clinical, laboratory and experimental practices of haematology.
John Barrett MD – Editor in Chief commented: “The BJHaem editorial team are delighted to share the news of our 2022 Impact factor which has risen to 8.6 its highest value ever as far as our records show. While all medical journals have generally shown an increase related to the COVID-19 pandemic, the BJHaem has also increased its impact through global outreach. We are proud that we have such global reach and can provide a platform to disseminate the best British haematology research to a global audience – if you have important research to publish please do consider submitting your next paper to us and be read by haematologists around the world. “
BSH Full members can enjoy free access to BJHaem both online and print copies (which can be sent to home/work addresses.) Sign up for your membership here